• About the company
    • Who We Are
    • Philosophy
    • History
    • Managment
    • Sustainable Development
    • Reporting
  • Products
    • Product Catalog
    • Pharmacovigilance
    • Surveillance of Medical Devices
    • Library
  • R&D
    • R&D Hub
    • R&D Strategy
    • Therapeutic Focuses
    • Technologies
    • R&D Culture
    • Partnerships
    • Join the R&D Team
  • Career
    • About Us
    • Profi Day
    • Job Vacancies
    • Covid-19
  • For Partners
    • For Distributors
    • Partnerships
  • Media-Center
    • For Media
    • News
  • Contacts
  • Eng
    • Укр
    • Рус
  • Eng
    • Укр
    • Рус
  • About the company
    • Who We Are
    • Philosophy
    • History
    • Managment
    • Sustainable Development
    • Reporting
  • Products
    • Product Catalog
    • Pharmacovigilance
    • Surveillance of Medical Devices
    • Library
  • R&D
    • R&D Hub
    • R&D Strategy
    • Therapeutic Focuses
    • Technologies
    • R&D Culture
    • Partnerships
    • Join the R&D Team
  • Career
    • About Us
    • Profi Day
    • Job Vacancies
    • Covid-19
  • For Partners
    • For Distributors
    • Partnerships
  • Media-Center
    • For Media
    • News
  • Contacts
Home » Nebulizer accessories » Nasal cannula for Ulaizer™ Home

Nasal cannula for Ulaizer™ Home

Nasal cannula is used for nasal inhalation only.

As well as a mouthpiece or a mask, the cannula is attached to the outlet of the nebulizer chamber, which supplies fine therapeutic agents.

Sales markets

Uzbekistan, Kyrgyzstan, Moldova, Romania, Tajikistan, Ukraine.

Download manual (3 MB, pdf)
  • Leave a Feedback about the medical device
Where to buy
  • Online store Ulaizer
Drug website
www.ulaizer.com.ua
Category
Nebulizer accessories Nebulizers (inhalers) Ulaizer
Other drugs in this category
Filters for Ulaizer™ Home
The Ulaizer therapy
Masks (paediatric + adult) for Ulaizer™ Home
ULAIZER™ PRO
ULAIZER™ FIRST AID
The Ulaizer™ Home
THE ULAIZER™ AIR
Ulaizer™ Air+
Nebulizer chamber for Ulaizer™ Home
Air tubing for Ulaizer™ Home

Learn more

BioGENext Conference 2026: Laying the ground for world-class biomedical research in Ukraine
R&D

BioGENext Conference 2026: Laying the ground for world-class biomedical research in Ukraine

YURiA-PHARM strengthens its presence in Uzbekistan: company ranks No. 2 in the market, Reosorbilact and Tivortin top the brand ranking
Growth

YURiA-PHARM strengthens its presence in Uzbekistan: company ranks No. 2 in the market, Reosorbilact and Tivortin top the brand ranking

Implementation of the Methacholine Bronchial Challenge Test in Ukraine
New products

Implementation of the Methacholine Bronchial Challenge Test in Ukraine

This site uses cookies to give you a better browsing experience, you can find out more about the cookies we use here Confidentiality Policy
Accept

Sign for health professionals

If you are a health care professional, as a confirmation, press «ENTER» to get started.
  • About the company
    • Who We Are
    • Philosophy
    • History
    • Managment
    • Sustainable Development
    • Reporting
  • Products
    • Product Catalog
    • Pharmacovigilance
    • Surveillance of Medical Devices
    • Library
  • R&D
    • R&D Hub
    • R&D Strategy
    • Therapeutic Focuses
    • Technologies
    • R&D Culture
    • Partnerships
    • Join the R&D Team
  • Career
    • About Us
    • Profi Day
    • Job Vacancies
    • Covid-19
  • For Partners
    • For Distributors
    • Partnerships
  • Media-Center
    • For Media
    • News
  • Contacts
  • Confidentiality Policy
  • All products
  • All library articles
Feedback
  • Product sites:
    • Artro-Patch (LV)
    • Izota (EN)
    • Instylan (EN, IT, ES, FR, PL, CS)
    • Xavron (EN)
    • Tivortin (EN)
    • Ulaizer (EN)
    • Revul (EN)
Follow us

Contact form

    Delete
    Delete
    Delete
    Delete
    Delete